Neurol. praxi. 2013;14(6):319-320

New trends in physiotherapy of people with multiple sclerosis

PhDr.Kamila Řasová, Ph.D.
Klinika rehabilitačního lékařství 3. LF UK a FN KV v Praze

In the synoptic article the authoress presents mechanisms of physiotherapeutic effect and principles of contemporary approach in

physiotherapy (examination and therapy) in people with multiple sclerosis.

plasticity and adaptability of the central nervous system, immunomodulation.

Keywords: multiple sclerosis, rehabilitation, physiotherapy, muscle re-education approach, facilitation approach, task-oriented approach,

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Řasová K. New trends in physiotherapy of people with multiple sclerosis. Neurol. praxi. 2013;14(6):319-320.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bains JS, Oliet SH. Glia: they make your memories stick! Trends Neurosci. 2007; 30: 417-424. Go to original source... Go to PubMed...
    2. Boldyrev AA, Carpenter DO, Johnson P. Emerging evidence for a similar role ofglutamate receptors in the nervous and immune systems. J. Neurochem. 2005; 95: 913-918. Go to original source... Go to PubMed...
    3. Bovend'Eerdt TJH, Botell RE, Wade DT. Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide. Clin Rehabil. 2009; 23: 352-361. Go to original source... Go to PubMed...
    4. Castellano V, Patel DI, White LJ. Cytokine responses to acute and chronic exercise in multiple sclerosis. Appl Physiol. 2008; 104(6): 1697-1702. Go to original source... Go to PubMed...
    5. Faissner A, Kettenmann H, Trotter J. A critical review of contemporary therapies. In: Comprehensive Human Physiology (Greger R, Windhorst U, eds.), Berlin, Springer-Verlag. 1996; 96-108.
    6. Heesen C, Gold SM, Hartmann S, Mladek M, Reer R, Braumann KM, Wiedemann K, Schulz KH. Endocrine and cytokine responses to standardized physical stress in multiple sclerosis. Brain Behav Immun. 2003; 17(6): 473-481. Go to original source... Go to PubMed...
    7. Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung, HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 2002; 3: 291-301. Go to original source... Go to PubMed...
    8. Henze T, Rieckmann P, Toyka KV. Symptomatic treatment of Multiple Sclerosis. Eur. Neurol. 2006; 56: 78-105. Go to original source... Go to PubMed...
    9. Ibrahim I, Tintera J, Skoch A, Jiru F, Hlustik P, Martinkova P, Zvara K, Rasova K. Fractional anisotropy and mean diffusivity in the corpus callosum of patients with multiple sclerosis: the effect of physiotherapy, accepted by Neuroradiology. 2011 Nov; 53(11): 917-926. DOI: 10.1007/s00234-011-0879-6. Go to original source... Go to PubMed...
    10. Kern S, Ziemssen T. Brain-immune communication psychoneuroimmunology of multiple sclerosis. Mult Scler. 2008; 14(1): 6-21. Go to original source... Go to PubMed...
    11. Kolar P. Facilitation of agonist-antagonist co-activation by reflex stimulation methods. In: Liebenson C (ed) Rehabilitation of the spine, 2nd edn. Lippincott, Philadelphia. 2007; 532-565.
    12. Matthews PM, Johansen-Berg H, Reddy H. Non-invasive mapping of brain functions and brain recovery: Applying lessons from cognitive neuroscience to neurorehabilitation. Restorative Neurology and Neuroscience. 2004; 22: 245-260. Go to PubMed...
    13. Molitari M, Filippini V, Leggio MG. Neuronal plasticity of interreleated cerebellar and cortical network. Neuroscience. 2002; 111: 863-870. Go to original source... Go to PubMed...
    14. Morgen K, Kadom N, Sawaki L, Tessitore A, Ohayon J, McFarland H, Frank J, Martin R, Cohen LG. Training-dependent plasticity in patients with multiple sclerosis. Brain. 2004; 127(11): 2506-2517. Go to original source... Go to PubMed...
    15. Polman CH, O´Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW, AFFIRM Investigators. A randomised, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006; 354(9): 899-910. Go to original source... Go to PubMed...
    16. Rasova K, Krasensky J, Havrdova E, Obenberger J, Seidel Z, Dolezal O. Is it possible to actively and purposely make use of plasticity and adaptability in the neurorehabilitation treatment of Multiple Sclerosis patients? Pilot Project. Clinical Rehabilitation. 2005; 19: 170-181. Go to original source... Go to PubMed...
    17. Rasova K, Feys P, Henze T, Herbenova A, Tongeren VH, Cattaneo D, Jonsdottir J. Emerging evidence-based physical rehabilitation for Multiple Sclerosis - Towards an inventory of current content across Europe. Health and Quality of Life Outcomes. 2010; 8: 76. Go to original source... Go to PubMed...
    18. Rasova K, Kalistova H, Kucera P, Juzova O, Zimova D, Medova E, Dolezil D, Jandova D, Tintera J, Ibrahim I, Zvara K, Bicikova M, Martinkova P. Physiotherapy as an immunoactive therapy? A pilot study. Neuroendocrinol Lett. 2012; 33(1): 67-75. Go to PubMed...
    19. Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, Reer R, Braumann KM, Heesen. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci. 2004; 225(1-2): 11-18. Go to original source... Go to PubMed...
    20. Health Organization. International Classification of Functioning, Disability and Health (ICF). Pocket-sized Book. 2001

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.